POLUZZI, ELISABETTA
 Distribuzione geografica
Continente #
EU - Europa 2.416
NA - Nord America 1.454
AS - Asia 498
AF - Africa 20
OC - Oceania 18
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.415
Nazione #
FR - Francia 1.609
US - Stati Uniti d'America 1.422
CN - Cina 251
IT - Italia 208
IE - Irlanda 112
GB - Regno Unito 98
SE - Svezia 96
DE - Germania 95
JP - Giappone 64
BG - Bulgaria 52
IN - India 44
CA - Canada 31
HK - Hong Kong 31
AT - Austria 28
SA - Arabia Saudita 24
KR - Corea 20
AU - Australia 17
ES - Italia 17
NL - Olanda 16
IL - Israele 15
FI - Finlandia 13
BE - Belgio 10
DK - Danimarca 10
IR - Iran 10
RU - Federazione Russa 8
SG - Singapore 8
TR - Turchia 8
CZ - Repubblica Ceca 7
CL - Cile 5
EG - Egitto 5
PL - Polonia 5
RO - Romania 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
MT - Malta 4
TW - Taiwan 4
UA - Ucraina 4
CH - Svizzera 3
GH - Ghana 3
GR - Grecia 3
HR - Croazia 3
ID - Indonesia 3
MY - Malesia 3
VN - Vietnam 3
BR - Brasile 2
LT - Lituania 2
NG - Nigeria 2
PK - Pakistan 2
PT - Portogallo 2
SM - San Marino 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
LV - Lettonia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.415
Città #
Paris 347
Ashburn 299
Dublin 110
Santa Cruz 84
Bologna 68
Fairfield 64
Houston 53
Sofia 52
Seattle 43
Stockholm 40
Chicago 37
Beijing 36
Woodbridge 36
Buffalo 34
Guangzhou 31
Fleming Island 29
Boardman 28
Ann Arbor 25
Shanghai 23
Southend 22
Vienna 21
Cambridge 20
Mountain View 19
New York 19
Wuhan 19
Wilmington 18
London 17
Los Angeles 15
San Diego 15
Central District 13
Munich 13
Cedar Knolls 12
Chandler 12
Giv‘atayim 12
Helsinki 12
Ottawa 12
Council Bluffs 11
Tokyo 11
Florence 10
Frankfurt am Main 10
Hangzhou 10
Miami 10
Las Vegas 9
Rimini 9
Riyadh 9
Bremen 8
Brooklyn 8
Brussels 8
Chengdu 8
Copenhagen 8
Hong Kong 8
Orlando 8
Oviedo 8
Berlin 7
Cesena 7
Henderson 7
Istanbul 7
Rome 7
Shenyang 7
Amsterdam 6
Bradford 6
Changsha 6
Clearwater 6
Dallas 6
Liverpool 6
Toronto 6
Atlanta 5
Bengaluru 5
Duncan 5
Milan 5
Pievepelago 5
Riva 5
San Francisco 5
Seoul 5
Gunzenhausen 4
Lake Forest 4
Langon 4
Minneapolis 4
Modena 4
Moscow 4
Muizenberg 4
Phoenix 4
Provo 4
Rotterdam 4
Accra 3
Bari 3
Birmingham 3
Boston 3
Chandigarh 3
Chions 3
Dong Ket 3
Esslingen am Neckar 3
Grenoble 3
Harbin 3
Hazratpur 3
Hefei 3
Herndon 3
Hillsborough 3
Jakarta 3
Kobe 3
Totale 2.075
Nome #
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, file eb99cc56-d170-4e04-9da3-fdf46797d63f 769
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, file e1dcb337-c798-7715-e053-1705fe0a6cc9 529
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, file e1dcb337-e6de-7715-e053-1705fe0a6cc9 384
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb338-737f-7715-e053-1705fe0a6cc9 364
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?, file e1dcb336-78d5-7715-e053-1705fe0a6cc9 202
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems, file e1dcb339-e747-7715-e053-1705fe0a6cc9 170
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance, file e1dcb33a-12f3-7715-e053-1705fe0a6cc9 145
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., file e1dcb332-756f-7715-e053-1705fe0a6cc9 119
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance, file e1dcb338-b213-7715-e053-1705fe0a6cc9 113
Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health, file e1dcb331-9448-7715-e053-1705fe0a6cc9 108
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study, file 7dce657a-d196-46b2-8baa-7482ac50b35b 105
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres, file e1dcb332-9652-7715-e053-1705fe0a6cc9 97
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature, file e1dcb331-d6bb-7715-e053-1705fe0a6cc9 89
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe, file e1dcb32d-4e3f-7715-e053-1705fe0a6cc9 82
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas, file e1dcb334-f81b-7715-e053-1705fe0a6cc9 76
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements, file e1dcb336-fb0d-7715-e053-1705fe0a6cc9 63
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study', file e1dcb336-dc47-7715-e053-1705fe0a6cc9 62
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit, file e1dcb32f-4c6b-7715-e053-1705fe0a6cc9 56
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb338-8430-7715-e053-1705fe0a6cc9 47
Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?, file e1dcb331-8ba1-7715-e053-1705fe0a6cc9 44
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies, file a06b9444-daa6-4544-83b0-ba76f0d76428 42
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies, file 42c8c724-e4be-4b4b-80d7-9e9049eb1e75 36
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, file e1dcb336-bed1-7715-e053-1705fe0a6cc9 34
The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System, file 784c07f7-46ac-4a7d-bf08-9b5707e72415 31
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study, file d38ede64-ca6e-44d3-96d3-0eab14cb084c 29
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region, file e1dcb339-d2a0-7715-e053-1705fe0a6cc9 26
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, file eaca171a-ce1e-41f6-8a42-667f6cbdd357 26
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System, file e1dcb32e-178b-7715-e053-1705fe0a6cc9 25
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, file cf7d8fc4-5a7e-40a8-a176-6b5dab7929fe 24
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions, file e1dcb336-73cc-7715-e053-1705fe0a6cc9 23
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study, file e1dcb337-4310-7715-e053-1705fe0a6cc9 23
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System, file c0101686-5837-4606-9b30-a38e2ac32429 22
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region, file 2f3b6736-cc5f-4d86-817b-d4a582642dbb 20
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials, file c1c104d0-a8ff-4958-b4fd-02ee623d15a2 20
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People, file 463640af-159b-41c1-b35f-8828f6a7a1f8 19
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, file b13c0892-9f32-4bcd-b5fc-33e5d085b827 19
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., file e1dcb332-7570-7715-e053-1705fe0a6cc9 18
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions, file 2f52c8e7-78d5-4925-861d-717e1395a63c 16
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, file 4c1ab21e-4a86-468f-b565-8fdfefa93759 16
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, file 7c410862-ff85-4949-8435-13e6f23a0bd6 16
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe., file e1dcb332-7571-7715-e053-1705fe0a6cc9 16
Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, file e1dcb339-4063-7715-e053-1705fe0a6cc9 15
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file e1dcb339-4230-7715-e053-1705fe0a6cc9 15
Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology, file e1dcb339-8e22-7715-e053-1705fe0a6cc9 14
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file 28c2f26d-ce73-4fb5-babf-66681de692e8 13
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database., file e1dcb32b-be51-7715-e053-1705fe0a6cc9 12
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System, file e1dcb331-c79f-7715-e053-1705fe0a6cc9 12
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry, file e1dcb338-5348-7715-e053-1705fe0a6cc9 12
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance, file e1dcb339-da19-7715-e053-1705fe0a6cc9 12
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal, file 69f80cdd-a0a4-4c80-80bc-ab3e66a45bce 11
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, file e1dcb336-c7d6-7715-e053-1705fe0a6cc9 11
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database, file e1dcb335-f680-7715-e053-1705fe0a6cc9 10
Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology, file 4c6bf437-ac77-4012-8cb0-d253ea4cab7a 9
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, file e1dcb337-c79b-7715-e053-1705fe0a6cc9 9
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System, file b0a11f88-d7a2-4b48-a3ae-9841a77cd29c 8
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file c0395b8a-a717-4186-aa67-37c2b908c849 8
SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?, file e1dcb336-ddb0-7715-e053-1705fe0a6cc9 8
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, file 53409f97-32db-4375-902c-7158f2fb15df 7
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database, file d6a1690d-3e94-42d9-a26a-e8dcd9683974 7
Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study, file 369b174c-3ebe-425d-84f8-372e94ab708d 6
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment, file 46fe2111-4d49-4e50-b12d-b45022612301 6
Medication Use and Costs Among Older Adults Aged 90 Years and Older in Italy, file 5a5ad938-b398-4f11-990e-7f21085aaa68 6
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, file 7a76f612-27e6-4fff-b791-a1bf5aa6142b 6
Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study, file c623efb5-a4a6-47ff-92bd-1e1c4f664733 6
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective, file e1dcb32c-ce26-7715-e053-1705fe0a6cc9 6
Global prevalence of antidepressant utilization in the community: A protocol for a systematic review, file 3b8eddf0-3dcb-4723-9e76-61c6ca2cd2b7 5
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase, file 682d5bcd-e075-47cf-8b73-1681beb917b8 5
Medication use in Italian nursing homes: preliminary results from the national monitoring system, file 7dd3a68d-bc80-49cd-918a-7fc944769080 5
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System, file 9872e675-f479-47c9-9867-28b38909c2aa 5
ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance, file bcddef07-ebab-4cd8-b04f-c6f4f5a76ef6 5
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database, file e1dcb32d-1c38-7715-e053-1705fe0a6cc9 5
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis, file 283fb261-c43d-4dd8-8c7a-5af22d135f22 4
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey, file e1dcb32d-1c3d-7715-e053-1705fe0a6cc9 4
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia, file e1dcb336-6202-7715-e053-1705fe0a6cc9 4
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, file e1dcb33a-2f36-7715-e053-1705fe0a6cc9 4
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems, file e1dcb33a-2f37-7715-e053-1705fe0a6cc9 4
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance, file 2f3b150d-32e4-4c62-81d7-061ed79cd9e0 3
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System, file 6123cec3-26d5-4009-92d8-fa4f5b109c33 3
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection, file e1dcb32d-ed91-7715-e053-1705fe0a6cc9 3
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping, file e1dcb330-9165-7715-e053-1705fe0a6cc9 3
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb331-0899-7715-e053-1705fe0a6cc9 3
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors, file e1dcb335-55dd-7715-e053-1705fe0a6cc9 3
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, file 1be23e9b-59ba-4baf-936b-bd717c99497f 2
Medication Use and Costs Among Older Adults Aged 90 Years and Older in Italy, file 2e3c39a7-d876-4dbc-9bf0-85bb0ef54b28 2
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct, file 5f13a1ec-8185-4261-bfbe-fadc1cc55f64 2
Medication use in Italian nursing homes: preliminary results from the national monitoring system, file 7b179887-fac6-49af-a666-cd6cc2262247 2
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, file 7b662054-0d67-4bd9-a369-d9a607f9600d 2
Comparison of drug prescribing before and during the COVID-19 pandemic: A cross-national European study, file cf50b922-16ec-4561-a01d-3672b9d1dd2f 2
Macrolides and Torsadogenic Risk: Emerging Issues from the FDA Pharmacovigilance Database, file e1dcb32c-623f-7715-e053-1705fe0a6cc9 2
null, file e1dcb32d-dc84-7715-e053-1705fe0a6cc9 2
Stroke, Migraine and Triptans: From Bedside to Bench, file e1dcb32e-68fc-7715-e053-1705fe0a6cc9 2
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb331-089a-7715-e053-1705fe0a6cc9 2
Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety, file e1dcb333-f0af-7715-e053-1705fe0a6cc9 2
Use of azithromycin and risk of ventricular arrhythmia, file e1dcb336-3681-7715-e053-1705fe0a6cc9 2
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study, file 185cc669-d236-42f3-9712-502b2306e2b3 1
Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study, file 204ab1d1-8fce-4093-b095-f5a14da79d3d 1
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list?, file 39a3b588-aefd-4061-84bb-e55ba8464ef8 1
Impact of the COVID-19 Pandemic on the Therapeutic Continuity among Outpatients with Chronic Cardiovascular Therapies, file 406e7fee-32b2-444b-8df6-445f3d608d04 1
Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study, file 9750e3ea-71bc-40e0-b3eb-00f19d7b66ff 1
Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System, file c55c04d5-9141-4d2a-ac6d-aed2ce766968 1
Totale 4.452
Categoria #
all - tutte 9.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/2020167 8 3 3 13 19 11 23 19 26 20 10 12
2020/2021159 10 14 7 7 2 21 4 23 15 16 21 19
2021/2022693 36 52 56 88 75 41 40 39 49 40 122 55
2022/2023880 22 38 111 94 59 44 74 51 162 75 112 38
2023/20242.556 50 79 170 230 84 1.181 400 362 0 0 0 0
Totale 4.469